{"?xml":{"@version":"1.0"},"edm:RDF":{"@xmlns:dc":"http://purl.org/dc/elements/1.1/","@xmlns:edm":"http://www.europeana.eu/schemas/edm/","@xmlns:wgs84_pos":"http://www.w3.org/2003/01/geo/wgs84_pos","@xmlns:foaf":"http://xmlns.com/foaf/0.1/","@xmlns:rdaGr2":"http://rdvocab.info/ElementsGr2","@xmlns:oai":"http://www.openarchives.org/OAI/2.0/","@xmlns:owl":"http://www.w3.org/2002/07/owl#","@xmlns:rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","@xmlns:ore":"http://www.openarchives.org/ore/terms/","@xmlns:skos":"http://www.w3.org/2004/02/skos/core#","@xmlns:dcterms":"http://purl.org/dc/terms/","edm:WebResource":[{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-UWV52LQH/55428a27-793a-487d-b397-03336fca5019/HTML","dcterms:extent":"34 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-UWV52LQH/03b8a205-2fad-47d6-8e3c-207221d7783e/PDF","dcterms:extent":"436 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-UWV52LQH/04797da6-7234-4c0a-bbee-cbfce48e1a23/TEXT","dcterms:extent":"30 KB"}],"edm:TimeSpan":{"@rdf:about":"1929-2026","edm:begin":{"@xml:lang":"en","#text":"1929"},"edm:end":{"@xml:lang":"en","#text":"2026"}},"edm:ProvidedCHO":{"@rdf:about":"URN:NBN:SI:doc-UWV52LQH","dcterms:isPartOf":[{"@rdf:resource":"https://www.dlib.si/details/urn:nbn:si:spr-a30mfzkp"},{"@xml:lang":"sl","#text":"Zdravniški vestnik"}],"dcterms:issued":"2010","dc:creator":"Tomažič, Janez","dc:format":[{"@xml:lang":"sl","#text":"številka:10"},{"@xml:lang":"sl","#text":"letnik:79"},{"@xml:lang":"sl","#text":"9 strani"},{"@xml:lang":"sl","#text":"str. 726-734"}],"dc:identifier":["ISSN:1318-0347","COBISSID:27498457","URN:URN:NBN:SI:doc-UWV52LQH"],"dc:language":"sl","dc:publisher":{"@xml:lang":"sl","#text":"Slovensko zdravniško društvo"},"dc:subject":[{"@xml:lang":"en","#text":"Adverse Effects"},{"@xml:lang":"en","#text":"Antagonists And Inhibitors"},{"@xml:lang":"en","#text":"Antibodies, Monoclonal"},{"@xml:lang":"sl","#text":"biološka zdravila"},{"@xml:lang":"en","#text":"Drug Therapy"},{"@xml:lang":"en","#text":"Immunology"},{"@xml:lang":"en","#text":"Infection"},{"@xml:lang":"sl","#text":"Infekcija"},{"@xml:lang":"sl","#text":"infekcije"},{"@xml:lang":"en","#text":"Neoplasms"},{"@xml:lang":"sl","#text":"Novotvorbe"},{"@xml:lang":"sl","#text":"Protitelesa monoklonska"},{"@xml:lang":"sl","#text":"rak (medicina)"},{"@xml:lang":"sl","#text":"Revmatične bolezni"},{"@xml:lang":"en","#text":"Rheumatic Diseases"},{"@xml:lang":"en","#text":"therapy"},{"@xml:lang":"en","#text":"tumor"},{"@xml:lang":"en","#text":"Tumor Necrosis Factor"},{"@xml:lang":"sl","#text":"Tumor nekrotizirajoči faktor"},{"@xml:lang":"sl","#text":"zapleti"},{"@xml:lang":"sl","#text":"zdravljenje"}],"dcterms:temporal":{"@rdf:resource":"1929-2026"},"dc:title":{"@xml:lang":"sl","#text":"Biološka zdravila in okužbe| Biologicals and infections| Biologicals and infections|"},"dc:description":{"@xml:lang":"sl","#text":"As biological agents interfere with immunity, there are potential concerns regarding increased rates of both common and unusual infections among treated patients. While most biologicals are generally safe, agents that inhibit tumornecrosis factor alpha and monoclonal antibodies against specific subsets of leukocytes may cause different, sometimes life threating infectious complications. The aim of this review is to present a comprehensive overview of the infectious risks associated with most important biological agents"},"edm:type":"TEXT","dc:type":[{"@xml:lang":"sl","#text":"znanstveno časopisje"},{"@xml:lang":"en","#text":"journals"},{"@rdf:resource":"http://www.wikidata.org/entity/Q361785"}]},"ore:Aggregation":{"@rdf:about":"http://www.dlib.si/?URN=URN:NBN:SI:doc-UWV52LQH","edm:aggregatedCHO":{"@rdf:resource":"URN:NBN:SI:doc-UWV52LQH"},"edm:isShownBy":{"@rdf:resource":"http://www.dlib.si/stream/URN:NBN:SI:doc-UWV52LQH/03b8a205-2fad-47d6-8e3c-207221d7783e/PDF"},"edm:rights":{"@rdf:resource":"http://creativecommons.org/licenses/by-nc/4.0/"},"edm:provider":"Slovenian National E-content Aggregator","edm:intermediateProvider":{"@xml:lang":"en","#text":"National and University Library of Slovenia"},"edm:dataProvider":{"@xml:lang":"sl","#text":"Slovensko zdravniško društvo"},"edm:object":{"@rdf:resource":"http://www.dlib.si/streamdb/URN:NBN:SI:doc-UWV52LQH/maxi/edm"},"edm:isShownAt":{"@rdf:resource":"http://www.dlib.si/details/URN:NBN:SI:doc-UWV52LQH"}}}}